Green Cross: Individuals Net Sell 157,638 Shares Over 5 Days... Stock Price at 259,000 KRW (-3.54%)

As of 1:30 p.m. on October 27, Green Cross is trading at 259,000 KRW, down 3.54% from the previous day. The trading volume stands at 263,738 shares, which is 32.28% of the previous day's trading volume. Green Cross is known as a pharmaceutical company specializing in blood products and vaccines.

On October 23, Lee Hyerin, a researcher at KTB Investment & Securities, stated, "The signing of a COVID-19 vaccine CMO agreement with CEPI (Coalition for Epidemic Preparedness Innovations) is a surprising development. We expect concrete CMO contracts with multiple global pharmaceutical companies in the future. While it is difficult to guarantee the long-term sustainability of the COVID-19 vaccine business, it is expected to serve as a cash cow in the short to medium term." She set the target price for Green Cross at 300,000 KRW.

Over the past five days, individual investors have recorded a net sale of 157,638 shares of Green Cross, while foreign investors and institutions have recorded net purchases of 65,790 shares and 86,240 shares, respectively.

※ Source: AI investment assistant AI Rassiro

※ This article was automatically generated in real time by a news generation algorithm jointly developed by Asia Economy and the financial AI specialist company ThinkPool.

This content was produced with the assistance of AI translation services.